Molecular characterization of neuroendocrine prostate cancer and identification of new drug targets Academic Article uri icon

Overview

MeSH Major

  • Antineoplastic Agents
  • Neuroendocrine Tumors
  • Prostatic Neoplasms
  • Protein Kinase Inhibitors

abstract

  • We report on the largest in-depth molecular analysis of NEPC and provide new insight into molecular events involved in the progression of prostate cancer.

publication date

  • November 2011

Research

keywords

  • Academic Article

Identity

Language

  • eng

PubMed Central ID

  • PMC3290518

Digital Object Identifier (DOI)

  • 10.1158/2159-8290.CD-11-0130

PubMed ID

  • 22389870

Additional Document Info

start page

  • 487

end page

  • 95

volume

  • 1

number

  • 6